fda warning bpc-157 unapproved drug safety concerns Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Exciting news for peptides coming

Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for Health advisers begin meeting Thursday to review more than a half dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective. Full story FDA Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr. MedPage Today Advisers to the FDA back broad access to unapproved peptides, despite agency concerns FDA reviews unapproved peptides as popularity surges on social media

SKU: 76030146868 · From vanierexcavation.com